文章名稱引用次數(shù)

• Antibody-drug conjugate, GSK285 in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study58
• The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion57
• Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria47
• Pathogenesis of bone disease in multiple myeloma: from bench to bedside41
• Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting34
• Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma26
• Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts25
• Myelodysplastic syndromes current treatment algorithm 201824
• Chronic lymphocytic leukemia treatment algorithm 201820
• Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use19